Philips CPAP Cancer Lawsuit News

Royal Phillips Versus SoClean Inc. Could Determine The Outcome Of DreamStation CPAP Lawsuits

Phillips Inc. and others think that the SoClean Ozone Cleaning Solution is the cause of the machine's noise abatement foam degradation

Wednesday, December 1, 2021 - SoClean Inc. is accusing Phillips, the makers of the DreamStation CPAP sleep apnea machine and others that are currently under FDA recall, of selling old, returned, and defective sleep apnea machines as if they were new. Lawyersandsettlements.com (LS) tells readers that a recently filed lawsuit by SoClean claims that Phillips knowingly took in CPAP machines that were returned as defective, making minor repairs, and then shipping them to customers that paid for and assumed that they were brand new in a piece the company called Phillip's "Dirty Little Secret." The lawsuit states, "CPAP and BiPAP machines are often returned within a matter of weeks only to be refurbished and shipped out to other customers without their knowledge. This could feasibly happen up to 5-10 times with (what was assumed to be) new CPAP equipment," according to LS. SoClean states that there is no way to know the extent to which the device may have been cleaned or sanitized in between users is at all. Phillips accuses the SoClean Ozone cleaning solution of being the cause of the machine's noise abatement foam's degrading and that it was never approved. Phillips recall lawyers are filing lawsuits against the company for allegedly causing CPAP lung cancer and other debilitating respiratory illnesses. Phillips CPAP machines are accused of causing toxic particles, chemicals, and gasses to be released into the user's airways.

At issue here is the extent to which SoClean's Ozone cleaning solution produced high levels of toxic chemicals that contributed to CPAP foam degradation and also left toxic and dangerous chemicals in the CPAP device's mechanical airways to be inhaled by the CPAP user. LS has identified that to effectively clean the Phillips sleep devices it must produce Ozone levels that exceed those that the FDA deems to be safe. "to effectively sanitize, SoClean devices must emit levels of ozone that are higher than can be safely tolerated by humans or animals. Multiple studies have shown that high levels of ozone are known to be highly caustic and corrosive, especially if water is present." As a side note, SoClean is suing Phillips for 200 million dollars in what they said has been lost sales from the adverse publicity generated by the Phillips derogatory statements about their cleaning products. Coincidently, the drop in sales corresponded perfectly with users ceasing to use the CPAP device due to the recall, leading one to believe that CPAP customers may have been using the Ozone solution to clean their machines and stopped using the cleaning solution when they stopped using the sleep apnea device. LS also explains that two lawsuits against SoClean state that using the Ozone cleaning solution damages critical components of the device and leaves dangerously high levels of Ozone in the device's mask. The two lawsuits against SoClean also state that SoClean Inc. fraudulently misrepresented their product as containing no harsh chemicals according to LS.

More Recent Philips CPAP Cancer Lawsuit News:

Lawyers for CPAP Cancer Lawsuits

We will represent all persons in involved in a BiPAP or CPAP cancer lawsuit on a contingency basis, meaning there are never any legal fees unless we win compensation in your case. Anyone who developed cancer or another serious side effect as a result of using a Philips CPAP sleep apnea machine or ventilator in --or is a family member of such a person--is eligible to receive a free, no-obligation case review from our attorneys. Simply contact our firm through the online contact form or the chat feature and one of our Philips BiPAP cancer lawyers serving will contact you promptly to discuss your case.



Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.